Why IMA Stock advanced +1.24% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, IMA scores 19 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The fundamental cash engine pillar scores 1 out of 20, reflecting ROIC of -35% and an FCF yield of 0%. The whale and 13F flow pillar scores 3 out of 20 for institutional accumulation and options positioning. The insider conviction pillar scores 3 out of 20 based on SEC Form 4 and Congressional PTR cluster flow. The macro regime fit pillar scores 7 out of 20, tied to a beta of 1.0 and sector sensitivity. The forensic balance sheet pillar scores 5 out of 20, reflecting an Altman Z-Score of 0.2, a Piotroski F-Score of 1 out of 9, and a Debt/Equity ratio of 0.5. Taken together, the weakest pillars sit in the cash engine and insider conviction areas. For a prospective investor, the implication is that the rating's upside case rests almost entirely on a turnaround that the current cash generation data does not yet evidence. The valuation tradeoff is that a market capitalization of $46.0M against reported losses leaves little margin for error, and the forensic readings signal elevated distress risk rather than a cheap-entry opportunity.

Per the recent news wire, three items reference IMA. The most recent item, sourced from ad-hoc-news.de, is a headline stating that the stock is heading toward a November 11 earnings report (flagged YELLOW, MARKET WIRE). A second item from www.dars.gov.et reports the stock ending flat at $4.05, with support and resistance levels referenced at $3.85 and $4.25 (flagged GREEN, CATALYST). A third item from ad-hoc-news.de references a grant of 90,775 units and states the stock sits 55.71 percent below its high (flagged YELLOW, MARKET WIRE). The November 11 earnings date is the nearest identified catalyst. Per the Butterfly Supply-Chain Graph, no proprietary signals or butterfly links are present.

• What products or therapies generate the reported revenue, and what drove the decline from $9.2M in FY 2023 to $0.8M in FY 2025?
• What is the source of the increase in reported cash to $94.5M in FY 2025, and is it tied to financing, asset sales, or operations?
• What debt obligations exist, given that debt is reported as N/A across all periods?
• What does the November 11 earnings report need to show to alter the cash engine and forensic pillar readings?
• What is the reported share count and dilution history, given the grant of 90,775 units referenced in the news wire?